Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2005
11/09/2005EP1592684A1 Malonamide derivatives as gamma-secretase inhibitors
11/09/2005EP1592674A1 Amino 1, 3, 5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof and their use as herbicides and plant growth regulators
11/09/2005EP1592425A2 New arylpiperazinyl compounds
11/09/2005EP1592389A2 Piperazine-2-carboxamide derivatives
11/09/2005EP1423378B1 Aminopyrrole compounds as antiinflammatory agents
11/09/2005EP1315714B1 Quinazoline derivatives as alpha-1 adrenergic antagonists
11/09/2005EP1307196A4 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP1089973B1 Amidino and guanidino azetidinone tryptase inhibitors
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005EP1019392B1 Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
11/09/2005EP0943008B1 Metal mediated serine protease inhibitors
11/09/2005CN1694891A Neutral metallic dendrimer complexes
11/09/2005CN1694879A Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1694708A Inhibitors of tgfbeta
11/09/2005CN1226292C Diazesuberane derivant or its salt
11/09/2005CN1226035C New use of iloperidone
11/08/2005US6962996 Inhibitors of p38
11/08/2005US6962995 Phenanthroline derivatives
11/08/2005US6962942 Azacycloalkanone serine protease inhibitors
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962932 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
11/08/2005US6962924 Antihistamines; side effect reduction
11/08/2005US6962923 Pyrazole compositions
11/08/2005US6962917 E.g., (R)-2-(4-((4-fluoro-1H-benzimidazol-2-ylmethyl)-amino)-piperidin-1-yl)-1-(6- methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria
11/08/2005US6962913 Benzo-1,4-diazepin-2-ones as inhibitors of Aβ protein production
11/08/2005CA2249222C Aminopyridine derivatives
11/08/2005CA2195677C Endothelin antagonists
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103043A1 2, 4, 6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer’s disease
11/03/2005WO2005103041A2 Treatment of cns disorders using cns target modulators
11/03/2005WO2005103039A1 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists
11/03/2005WO2005103038A1 N-[6-(4-morpholinyl)-3-pyridinyl]-2-(tetrahydro-2h-pyran-4-yl)-n-[(1-{[phenyl]methyl}-4-piperidinyl)methyl] acetamide derivatives and related compounds as glyt1 transport inhibitors for the treatment of neurological disorders such as schizophrenia
11/03/2005WO2005103037A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005WO2005103036A1 Pyrimidin-4-yl-1h-indazol-5yl-amines as chk1 kinases inhibitors
11/03/2005WO2005103034A1 Novel piperidine substituted diaminothiazoles
11/03/2005WO2005103033A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005WO2005103032A2 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds
11/03/2005WO2005103031A1 Novel alkyne compounds with an mch-antagonistic action and medicaments containing said compounds
11/03/2005WO2005103030A1 1,4-di substituted benzene compounds, process for preparing the same and use thereof
11/03/2005WO2005103029A1 Novel alkyne compounds having an mch-antagonistic effect and medicaments containing said compounds
11/03/2005WO2005103028A1 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors
11/03/2005WO2005103006A1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
11/03/2005WO2005103002A2 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds
11/03/2005WO2005102998A1 Novel androgens
11/03/2005WO2005102997A1 3,4-disubstituted maleimides for use as vascular damaging agents
11/03/2005WO2005101989A2 Piperidine derivatives as modulators of chemokine receptor ccr5
11/03/2005WO2005086871A9 Compounds, compositions and methods for inhibiting or treating hiv-1
11/03/2005WO2005011611A3 Bicyclic compounds and compositions as pdf inhibitors
11/03/2005WO2005003103A3 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases
11/03/2005WO2004096131A3 Inhibitors of akt activity
11/03/2005WO2002004440A9 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
11/03/2005US20050245743 depression and/or anxiety, obesity, urinary disorder; 5-(2-Methoxyphenyl)-N-[3-(4-Piperidinyl)Phenyl]Pentanamide
11/03/2005US20050245596 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
11/03/2005US20050245593 4-Aminomethyl-1-aryl-cyclohexylamine compounds
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245586 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12
11/03/2005US20050245581 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents
11/03/2005US20050245580 Novel substituted dihydro 3-halo-1H-pyrazole-T-carboxylates, their preparation and use
11/03/2005US20050245578 Polymorphs of pantoprazole sodium salt and process for the preparation thereof
11/03/2005US20050245576 Substituted pyrazoles
11/03/2005US20050245574 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof
11/03/2005US20050245572 Naphthyl ether compounds and their use
11/03/2005US20050245571 Amine derivative
11/03/2005US20050245565 Diamine derivatives
11/03/2005US20050245555 Tri-substituted ureas as cytokine inhibitors
11/03/2005US20050245554 Substituted pyrimidines
11/03/2005US20050245552 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245547 6-((6,7-Bis(methoxy)-4-quinolinyl)oxy)-N-(3-methylphenyl)-1-benzofuran-3-carboxamide;antiproliferative; -metastasis; -carcinogenic; -tumor; -inflammatory; -arthritic agents;hypotensive agents; myocardium necrosis; rheumatic diseases; tyrosine kinase inhibitors; antiallergens; asthma
11/03/2005US20050245542 Pyridazine, pyrimidine and pyrazine ethyne compounds
11/03/2005US20050245538 Dipeptidyl peptidase inhibitor; antidiabetic agents; obesity; viricides; anticancer agents; oral diseases; autoimmune disease
11/03/2005US20050245536 N-Pyridyl-7-substituted-2-indolecarboxamides, e.g., 1-Methyl-7-[2-(4-methyl-piperazin-1-yl)-pyrimidin-4-yloxy]-1H-indole-2-carboxylic acid (2-tert-butyl-5-methoxy-pyridin-4-yl)-amide; used to treat chronic inflammatory diseases
11/03/2005US20050245530 Monocyclic heterocycles as kinase inhibitors
11/03/2005US20050245529 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
11/03/2005US20050245527 Nitrogen containing heterocyclic compounds and medicines containing the same
11/03/2005US20050245526 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
11/03/2005US20050245525 Compounds useful for inhibiting CHK1
11/03/2005US20050245523 Heteroaryl derivatives and their use as medicaments
11/03/2005US20050245521 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation
11/03/2005US20050245520 2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
11/03/2005US20050245515 Indolyl derivatives as liver-X-receptor (LXR) modulators
11/03/2005US20050245513 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245505 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
11/03/2005US20050245503 Therapeutic heterocycles
11/03/2005US20050245501 Succinoylamino lactams as inhibitors of A-beta protein production
11/03/2005US20050245500 Beta-ketoamide compounds with MCH antagonistic activity
11/03/2005US20050245499 Heterocyclic protein kinase inhibitors and uses thereof
11/03/2005US20050245485 Novel indole derivatives as selective androgen receptor modulators (SARMS)
11/03/2005US20050245399 Pyrazole derivatives as herbicidal compositions containing them
11/03/2005US20050244807 Two-photon absorption heteroaromatic chromophores and compositions thereof
11/03/2005DE19910403B4 3-Hydroxy-1,2,3,3a-tetrahydro-benzo[b]cyclopent[e]azepin-4,10(5H,10aH)-dion-Derivate enthaltende Arzneimittel 3-hydroxy-1,2,3,3a-tetrahydro-benzo [b] cyclopent [e] azepine-4,10 (5H, 10AH) -dione derivatives of drugs containing
11/03/2005DE102004018796A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
11/03/2005DE102004017935A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
1 ... 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 ... 1080